CD4 and neoplasm: Further supporting these findings, Noman et al. demonstrated that targeting VPS34 can suppress tumor growth and improve survival in various tumor models by increasing the infiltration of CD4+ T cells, CD8+ T cells, and NK cells into the tumor microenvironment [153].